Gene · 8932
Papers2,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk between Noncoding RNAs and the Epigenetics Machinery in Pediatric Tumors and Their Microenvironment. | Cancers (Basel) | 2023 | 37345170 | PubTator, text mining | PubMed |
| The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks? | Cancers (Basel) | 2023 | 37345131 | PubTator, text mining | PubMed |
| The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology. | Cancers (Basel) | 2023 | 37345019 | PubTator, text mining | PubMed |
| MRPL51 is a downstream target of FOXM1 in promoting the malignant behaviors of lung adenocarcinoma. | Oncol Lett | 2023 | 37323822 | PubTator, text mining | PubMed |
| Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma. | Cancer Res | 2023 | 37311054 | PubTator, text mining | PubMed |
| MBD2a-NuRD binds to the methylated γ-globin gene promoter and uniquely forms a complex required for silencing of HbF expression. | Proc Natl Acad Sci U S A | 2023 | 37307480 | PubTator, text mining | PubMed |
| The Mechanism of DNA Methylation and miRNA in Breast Cancer. | Int J Mol Sci | 2023 | 37298314 | PubTator, text mining | PubMed |
| Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter ABCA7 in Breast Cancer. | Cells | 2023 | 37296582 | PubTator, text mining | PubMed |
| The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things. | J Transl Med | 2023 | 37286982 | PubTator, text mining | PubMed |
| The Role of RNA Methylation Modification Related Genes in Prognosis and Immunotherapy of Colorectal Cancer. | Int J Gen Med | 2023 | 37284034 | PubTator, text mining | PubMed |
| Epigenetic regulation and therapeutic targets in the tumor microenvironment. | Mol Biomed | 2023 | 37273004 | PubTator, text mining | PubMed |
| Photoelectrochemical biosensor for DNA demethylase detection based on enzymatically induced double-stranded DNA digestion by endonuclease-exonuclease system and Bi4O5Br2-Au/CdS photoactive material. | Talanta | 2023 | 37245429 | PubTator, text mining | PubMed |
| SUMO1 Modification Stabilizes TET3 Protein and Increases Colorectal Cancer Radiation Therapy Sensitivity. | Int J Radiat Oncol Biol Phys | 2023 | 37244630 | PubTator, text mining | PubMed |
| Crosstalk between miRNAs and DNA Methylation in Cancer. | Genes (Basel) | 2023 | 37239435 | PubTator, text mining | PubMed |
| Hypoxia-induced loss of SRSF2-dependent DNA methylation promotes CTCF-mediated alternative splicing of VEGFA in breast cancer. | iScience | 2023 | 37235058 | PubTator, text mining | PubMed |
| Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer. | Cancer Cell Int | 2023 | 37231419 | PubTator, text mining | PubMed |
| Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37217462 | PubTator, text mining | PubMed |
| Methylated histones on mitotic chromosomes promote topoisomerase IIα function for high fidelity chromosome segregation. | iScience | 2023 | 37197327 | PubTator, text mining | PubMed |
| DNA methylation regulator-based signature for predicting clear cell renal cell carcinoma prognosis. | Am J Transl Res | 2023 | 37193150 | PubTator, text mining | PubMed |
| Intertwined regulation between RNA m6A modification and cancer metabolism. | Cell Insight | 2023 | 37192910 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8932/papers?page=13